SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2023 on November 7, 2023
24 Octubre 2023 - 4:50AM
SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company
and a leader in data-driven medicine, today announced it will
release its financial results for the third quarter of fiscal 2023
before U.S. markets open on Tuesday, November 7, 2023. On that day,
SOPHiA GENETICS will host a conference call to discuss its
financial results as well as business outlook beginning at 8:00
a.m. (08:00) EST / 2:00 p.m. (14:00) CEST.
The call will be webcast live on the SOPHiA GENETICS Investor
Relations website. Additionally, a replay will be available on the
website after its completion.
About SOPHiA GENETICS:SOPHiA GENETICS (Nasdaq:
SOPH) is a software company dedicated to establishing the practice
of data-driven medicine as the standard of care and for life
sciences research. It is the creator of the SOPHiA DDM™ Platform, a
cloud-native platform capable of analyzing data and generating
insights from complex multimodal data sets and different diagnostic
modalities. The SOPHiA DDM™ Platform and related solutions,
products and services are currently used by a broad network of
hospital, laboratory, and biopharma institutions globally. For more
information, visit SOPHiAGENETICS.COM, or connect
on Twitter, LinkedIn, Facebook,
and Instagram. Where others see data, we see
answers.
Investor Contact:Katherine BailonVP, Investor
Relationsir@sophiagenetics.com
Media Contact:Kelly KatapodisSenior Manager,
Media & Communicationsmedia@sophiagenetics.com
Sophia Genetics (NASDAQ:SOPH)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Sophia Genetics (NASDAQ:SOPH)
Gráfica de Acción Histórica
De May 2023 a May 2024